Hims
Hims is a wellness brand that helps the men get access to products for skin care, erectile dysfunction, and hair loss.
Launch date
Employees
Market cap
CAD4.7b
Enterprise valuation
CAD4.4b (Public information from Sep 2024)
Share price
$16.92 HIMS
San Francisco California (HQ)
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 149m | 272m | 527m | 872m | 1.4b | 1.9b | 2.3b |
% growth | 80 % | 83 % | 94 % | 65 % | 59 % | 36 % | 21 % |
EBITDA | (16.9m) | (111m) | (61.2m) | (19.9m) | 149m | 226m | 293m |
% EBITDA margin | (11 %) | (41 %) | (12 %) | (2 %) | 11 % | 12 % | 13 % |
Profit | (18.1m) | (108m) | (65.7m) | (23.5m) | 48.7m | 106m | 134m |
% profit margin | (12 %) | (40 %) | (12 %) | (3 %) | 4 % | 6 % | 6 % |
EV / revenue | 2.3x | 4.7x | 2.4x | 2.0x | 2.1x | 1.4x | 1.1x |
EV / EBITDA | -20.1x | -11.4x | -21.0x | -89.7x | 19.7x | 12.0x | 8.4x |
R&D budget | 11.2m | 22.4m | 29.2m | 48.2m | - | - | - |
R&D % of revenue | 8 % | 8 % | 6 % | 6 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
$7.0m | Series A | ||
$40.0m Valuation: $200m | Series B | ||
* | $50.0m Valuation: $350m | Series B | |
* | N/A | $100m Valuation: $1.0b | Late VC |
N/A | N/A | - | |
$205m Valuation: $1.6b 10.8x EV/LTM Revenues -94.6x EV/LTM EBITDA | SPAC IPO | ||
$75.0m Valuation: $1.6b 10.8x EV/LTM Revenues -94.6x EV/LTM EBITDA | SPAC Private Placement | ||
Total Funding | CAD371m |
Related Content
Recent News about Hims
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Hims
EditACQUISITION by Hims Jul 2021